$PRE

Prenetics Global Ltd

Prenetics is a consumer health company founded in Hong Kong in 2014 and headquartered in Quarry Bay, Hong Kong. Its business is organized around two brands: IM8, its flagship consumer health brand, and CircleDNA, its consumer genetic testing brand. Co-founded with David Beckham and launched in December 2024, IM8 sells science-backed supplements, including daily nutrition and longevity products. It sells exclusively through its direct-to-consumer online store and affiliated social media channels, using subscriptions and individual product purchases. Prenetics says IM8 products ship to more than 30 countries. CircleDNA uses next-generation sequencing to provide more than 500 personalized reports across 20+ categories, with four product tiers sold primarily through its website. Prenetics earns money from sales of IM8 supplements and CircleDNA genetic testing kits. Its products are manufactured by third parties; Prenetics does not maintain in-house manufacturing or distribution capability.

2
3
2

No SEC Form 4 filings for $PRE in the last 30 days.

See all $PRE insider activity →
Med

Prenetics Global reports Q3 results

Prenetics Global reported a Q3 net loss of $25.4M but revenue grew 171.6% year-over-year to $64.1M, exceeding estimates by $0.89M. The company's cash and current financial assets increased to $111.5M by September 30, 2026, up from $109.4M three months earlier.

Prenetics Global Ltd (PRE): Financial results for FY2027

Prenetics Global Ltd (PRE) furnished an SEC Form 6-K — earnings release. EX 99.1 Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+ — Total reven

Prenetics Global Q3 2026 Earnings Preview

Prenetics Global (PRE) will report Q3 2026 earnings on November 18th. Analysts expect an EPS of -$0.90, down 69.8% year-over-year, and revenue of $63.21M, up 167.8%.

PRE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 7 news stories mentioning PRE (Prenetics Global Ltd). Coverage has been balanced: 2 bullish, 3 neutral, and 2 bearish.

Recent PRE coverage spans earnings, financial news and corporate actions.

What's driving PRE

AlphAI scores every news story that mentions PRE with an AI model for sentiment and relevance, and aggregates insider trades from Prenetics Global Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PRE

Score

Prenetics Global reports Q3 results

Prenetics Global reported a Q3 net loss of $25.4M but revenue grew 171.6% year-over-year to $64.1M, exceeding estimates by $0.89M. The company's cash and current financial assets increased to $111.5M by September 30, 2026, up from $109.4M three months earlier.

$PREMedEarnings

Prenetics Global Ltd (PRE): Financial results for FY2027

Prenetics Global Ltd (PRE) furnished an SEC Form 6-K — earnings release. EX 99.1 Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+ — Total reven

Care Bears' first wellness brand plans gummy vitamins for kids and adults. Launch is targeted for first-half 2027.

Prenetics (NASDAQ: PRE) and Authentic Brands Group have partnered to launch Care Bears by IM8, a wellness brand offering gummy multivitamins for kids and adults, targeting a 2027 launch. Prenetics will record all revenue and pay royalties to Authentic. The global gummy supplements market is projected to reach $47.8 billion by 2030.

David Beckham co-founded health brand IM8, which accounts for nearly all Prenetics revenue. Rosin will lead finance.

Prenetics (Nasdaq: PRE) announced Brian J. Rosin will become CFO effective December 31, 2026, succeeding Stephen Lo. Rosin, currently CFO of IM8, will lead global finance. IM8, co-founded by David Beckham, generates nearly all of Prenetics' revenue. The company will report Q3 2026 results on November 18, 2026, with a live-streamed earnings event.

David Beckham co-founded IM8, now the NBA's nutrition partner. An NBA House fan event is planned for 2027.

The NBA and IM8, a health and longevity brand co-founded by David Beckham and owned by Prenetics Global (PRE), announced a multiyear partnership. IM8 becomes the Official Nutrition Partner in Australia and Southeast Asia, with plans for marketing campaigns and a 2027 NBA House fan event. IM8's flagship product, Daily Ultimate Essentials, is NSF Certified for Sport and ships to 46 countries.

Lucid Capital Markets initiates Prenetics stock with buy rating

Lucid Capital Markets initiated coverage on Prenetics (NASDAQ:PRE) with a Buy rating and $54 price target, citing its valuation and focus on IM8. The company reported a narrower-than-expected Q2 loss and revenue below estimates. StoneX and B.Riley also issued Buy ratings with targets of $40 and $37, respectively. Prenetics is shifting focus to IM8, a supplement brand co-founded with David Beckham.

AM Best Market Segment Report On Reinsurers

AM Best reports that a group of U.S. and Bermuda reinsurers maintained underwriting profitability in 2025, with a 16.8% net return on equity, despite slower premium growth. The composite includes seven companies, such as Arch Capital and Everest Group. Profitability was supported by higher investment income, but growth slowed to less than 1.0% due to market softening. AM Best expects muted growth in 2026 amid declining rates in property and casualty lines.

Related tickers